Source comparison
AHK-Cu vs TB-500: Research Peptide Comparison
Primary Mechanism Copper ion delivery, MMP modulation, collagen synthesis stimulation via TGF-β1 upregulation G-actin sequestration, cytoskeletal regulation, endothelial migration, NF-κB suppression AHK-Cu is copper-dependent enzymatic; TB-500 is actin-regulat
This comparison does not assign a generated winner or score.
- Primary Mechanism
- Copper ion delivery, MMP modulation, collagen synthesis stimulation via TGF-β1 upregulation
- G-actin sequestration, cytoskeletal regulation, endothelial migration, NF-κB suppression
- AHK-Cu is copper-dependent enzymatic; TB-500 is actin-regulatory systemic
- Optimal Tissue Types
- Dermal, epithelial, wound bed, aging skin models
- Cardiac, skeletal muscle, vascular endothelium, tendon, CNS
- TB-500 has broader systemic distribution; AHK-Cu is surface-tissue selective
- Research Applications
- Wound healing, photoaging, collagen turnover, fibrotic response studies, matrix remodeling
- Post-MI recovery, tendon repair, neuroprotection, angiogenesis, chronic inflammation models
- Choose based on tissue depth and repair pathway under investigation
- Typical Research Dose
- 1 nM–10 μM (in vitro); 0.001–0.01% topical (in vivo)
- 2–20 mg/kg body weight (in vivo animal models)
- Dosing scales differ by 1,000× due to mechanism and bioavailability differences
- Half-Life / Duration
- Tissue-dependent; copper remains chelated for 12–24 hours in dermal tissue
- ~10 hours plasma half-life; requires repeated dosing for sustained effect
- TB-500 requires more frequent administration to maintain tissue concentrations
- Storage Stability
- Stable at 2–8°C for 28 days when reconstituted; sensitive to chelating agents (EDTA)
- Stable at -20°C lyophilized; 30 days at 2–8°C reconstituted; avoid freeze-thaw cycles
- Both require cold chain; TB-500 more sensitive to temperature excursions
- Bottom Line
- Best for localized dermal repair, collagen studies, and copper-dependent matrix research
- Best for systemic repair, cardiac models, musculoskeletal injury, and actin-mediated processes
- AHK-Cu for surface/matrix; TB-500 for depth/motility. Not interchangeable